Related Experiment Video
Updated: Nov 4, 2025

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
Cardiopulmonary exercise testing in patients with Cardiac Amyloidosis
Divaya Bhutani1, Samuel Pan2, Farhana Latif3
1Division of Hematology and Oncology, Department of Medicine Columbia University Irving Medical Center.
Insights
Cardiopulmonary exercise testing reveals reduced functional capacity in cardiac amyloidosis patients. Findings suggest light chain toxicity contributes to cardiac dysfunction in AL amyloidosis.
Area of Science:
- Cardiology
- Cardiovascular Research
- Amyloidosis Research
Background:
- Cardiac involvement is frequent in AL and ATTR amyloidosis.
- Cardiopulmonary exercise testing (CPET) is the standard for assessing functional capacity.
Purpose of the Study:
- To evaluate CPET measurements in cardiac amyloidosis patients.
- To correlate CPET data with existing amyloidosis staging criteria.
Main Methods:
- Studied 41 patients with cardiac amyloidosis (AL and ATTR types).
- Analyzed cardiopulmonary exercise testing (CPET) parameters.
- Correlated CPET results with cardiac biomarker levels.
Main Results:
- Percent predicted peak VO2 was significantly reduced in both AL and ATTR cardiac amyloidosis.
- Reduced peak VO2 correlated with cardiac biomarker abnormalities.
- The association between peak VO2 and biomarkers was stronger in AL amyloidosis, suggesting light chain toxicity.
Conclusions:
- Findings provide further evidence for light chain toxicity in AL amyloidosis.
- CPET is a valuable tool for assessing functional capacity in cardiac amyloidosis.
Background:
Cardiac involvement and dysfunction are common in patients presenting with AL and ATTR Amyloidosis. Cardiopulmonary exercise testing (CPET) performance is the gold standard to quantify functional capacity.
Patients And Methods:
In this study, we evaluated CPET measurements in 41 patients with cardiac Amyloidosis and their correlation with current amyloid specific staging criteria.
Results:
In both AL and ATTR cardiac Amyloidosis, percent predicted peak VO2 is significantly reduced and correlates with biomarker abnormalities. The association of cardiac biomarkers with peak VO2 is stronger for AL Amyloidosis (NT-proBNP (r = -0.57, P=0.006), Troponin (r = -0.70, p < 0.001) than ATTR (NT-proBNP (r = -0.4, P = 0.04) and Troponin (r = -0.57, P = 0.002) despite lower left ventricular mass in the former, suggesting that this may be further evidence for light chain toxicity in AL amyloidosis.
Conclusion:
Our findings suggest further evidence for AL toxicity.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies

